ID   ETFD_HUMAN              Reviewed;         617 AA.
AC   Q16134; B4E3R9; J3KND9; Q7Z347;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   15-MAR-2017, entry version 164.
DE   RecName: Full=Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial;
DE            Short=ETF-QO;
DE            Short=ETF-ubiquinone oxidoreductase;
DE            EC=1.5.5.1;
DE   AltName: Full=Electron-transferring-flavoprotein dehydrogenase;
DE            Short=ETF dehydrogenase;
DE   Flags: Precursor;
GN   Name=ETFDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-31.
RC   TISSUE=Fetal liver;
RX   PubMed=8306995; DOI=10.1111/j.1432-1033.1994.tb19939.x;
RA   Goodman S.I., Axtell K.M., Bindoff L.A., Beard S.E., Gill R.E.,
RA   Frerman F.E.;
RT   "Molecular cloning and expression of a cDNA encoding human electron
RT   transfer flavoprotein-ubiquinone oxidoreductase.";
RL   Eur. J. Biochem. 219:277-286(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-31.
RC   TISSUE=Small intestine;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-31.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN GA2C.
RX   PubMed=12815589; DOI=10.1002/humu.10226;
RA   Olsen R.K.J., Andresen B.S., Christensen E., Bross P., Skovby F.,
RA   Gregersen N.;
RT   "Clear relationship between ETF/ETFDH genotype and phenotype in
RT   patients with multiple acyl-CoA dehydrogenation deficiency.";
RL   Hum. Mutat. 22:12-23(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-551, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANTS GA2C CYS-49; PHE-82; PRO-82; ARG-138; ASN-218; PRO-222;
RP   PHE-262; PRO-334; ARG-346; LYS-452; LEU-456; LEU-562 AND GLU-611, AND
RP   VARIANTS CYS-16 AND ILE-31.
RX   PubMed=12359134; DOI=10.1016/S1096-7192(02)00138-5;
RA   Goodman S.I., Binard R.J., Woontner M.R., Frerman F.E.;
RT   "Glutaric acidemia type II: gene structure and mutations of the
RT   electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO)
RT   gene.";
RL   Mol. Genet. Metab. 77:86-90(2002).
RN   [11]
RP   VARIANTS GA2C TYR-112 AND THR-456.
RX   PubMed=16527485; DOI=10.1016/j.nmd.2006.01.001;
RA   Beresford M.W., Pourfarzam M., Turnbull D.M., Davidson J.E.;
RT   "So doctor, what exactly is wrong with my muscles? Glutaric aciduria
RT   type II presenting in a teenager.";
RL   Neuromuscul. Disord. 16:269-273(2006).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-565.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [13]
RP   VARIANTS GA2C PRO-377; LEU-456; LEU-483 AND GLU-590.
RX   PubMed=17412732; DOI=10.1093/brain/awm054;
RA   Gempel K., Topaloglu H., Talim B., Schneiderat P., Schoser B.G.,
RA   Hans V.H., Palmafy B., Kale G., Tokatli A., Quinzii C., Hirano M.,
RA   Naini A., DiMauro S., Prokisch H., Lochmueller H., Horvath R.;
RT   "The myopathic form of coenzyme Q10 deficiency is caused by mutations
RT   in the electron-transferring-flavoprotein dehydrogenase (ETFDH)
RT   gene.";
RL   Brain 130:2037-2044(2007).
RN   [14]
RP   VARIANTS GA2C THR-84; HIS-127 AND LEU-175.
RX   PubMed=19249206; DOI=10.1016/j.nmd.2009.01.008;
RA   Liang W.C., Ohkuma A., Hayashi Y.K., Lopez L.C., Hirano M., Nonaka I.,
RA   Noguchi S., Chen L.H., Jong Y.J., Nishino I.;
RT   "ETFDH mutations, CoQ10 levels, and respiratory chain activities in
RT   patients with riboflavin-responsive multiple acyl-CoA dehydrogenase
RT   deficiency.";
RL   Neuromuscul. Disord. 19:212-216(2009).
RN   [15]
RP   VARIANTS GA2C THR-84 AND HIS-175.
RX   PubMed=20370797; DOI=10.1111/j.1399-0004.2010.01421.x;
RA   Lan M.Y., Fu M.H., Liu Y.F., Huang C.C., Chang Y.Y., Liu J.S.,
RA   Peng C.H., Chen S.S.;
RT   "High frequency of ETFDH c.250G>A mutation in Taiwanese patients with
RT   late-onset lipid storage myopathy.";
RL   Clin. Genet. 78:565-569(2010).
CC   -!- FUNCTION: Accepts electrons from ETF and reduces ubiquinone.
CC   -!- CATALYTIC ACTIVITY: Reduced electron-transferring flavoprotein +
CC       ubiquinone = electron-transferring flavoprotein + ubiquinol.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 1 [4Fe-4S] cluster.;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16134-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16134-3; Sequence=VSP_055158;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Glutaric aciduria 2C (GA2C) [MIM:231680]: An autosomal
CC       recessively inherited disorder of fatty acid, amino acid, and
CC       choline metabolism. It is characterized by multiple acyl-CoA
CC       dehydrogenase deficiencies resulting in large excretion not only
CC       of glutaric acid, but also of lactic, ethylmalonic, butyric,
CC       isobutyric, 2-methyl-butyric, and isovaleric acids.
CC       {ECO:0000269|PubMed:12359134, ECO:0000269|PubMed:12815589,
CC       ECO:0000269|PubMed:16527485, ECO:0000269|PubMed:17412732,
CC       ECO:0000269|PubMed:19249206, ECO:0000269|PubMed:20370797}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ETF-QO/FixC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD98030.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S69232; AAC60628.1; -; mRNA.
DR   EMBL; AK304838; BAG65581.1; -; mRNA.
DR   EMBL; BX538129; CAD98030.1; ALT_SEQ; mRNA.
DR   EMBL; AC107219; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011890; AAH11890.1; -; mRNA.
DR   CCDS; CCDS3800.1; -. [Q16134-1]
DR   CCDS; CCDS64090.1; -. [Q16134-3]
DR   PIR; S41115; S41115.
DR   RefSeq; NP_001268666.1; NM_001281737.1. [Q16134-3]
DR   RefSeq; NP_004444.2; NM_004453.3. [Q16134-1]
DR   UniGene; Hs.155729; -.
DR   ProteinModelPortal; Q16134; -.
DR   SMR; Q16134; -.
DR   BioGrid; 108411; 4.
DR   IntAct; Q16134; 8.
DR   STRING; 9606.ENSP00000426638; -.
DR   iPTMnet; Q16134; -.
DR   PhosphoSitePlus; Q16134; -.
DR   SwissPalm; Q16134; -.
DR   BioMuta; ETFDH; -.
DR   DMDM; 292495008; -.
DR   EPD; Q16134; -.
DR   MaxQB; Q16134; -.
DR   PaxDb; Q16134; -.
DR   PeptideAtlas; Q16134; -.
DR   PRIDE; Q16134; -.
DR   Ensembl; ENST00000307738; ENSP00000303552; ENSG00000171503. [Q16134-3]
DR   Ensembl; ENST00000511912; ENSP00000426638; ENSG00000171503. [Q16134-1]
DR   GeneID; 2110; -.
DR   KEGG; hsa:2110; -.
DR   UCSC; uc003iqb.5; human. [Q16134-1]
DR   CTD; 2110; -.
DR   DisGeNET; 2110; -.
DR   GeneCards; ETFDH; -.
DR   H-InvDB; HIX0200647; -.
DR   HGNC; HGNC:3483; ETFDH.
DR   HPA; HPA041978; -.
DR   MalaCards; ETFDH; -.
DR   MIM; 231675; gene.
DR   MIM; 231680; phenotype.
DR   neXtProt; NX_Q16134; -.
DR   OpenTargets; ENSG00000171503; -.
DR   Orphanet; 394532; Multiple acyl-CoA dehydrogenation deficiency, mild type.
DR   Orphanet; 394529; Multiple acyl-CoA dehydrogenation deficiency, severe neonatal type.
DR   PharmGKB; PA27899; -.
DR   eggNOG; KOG2415; Eukaryota.
DR   eggNOG; COG0644; LUCA.
DR   GeneTree; ENSGT00390000010773; -.
DR   HOGENOM; HOG000259450; -.
DR   HOVERGEN; HBG005615; -.
DR   InParanoid; Q16134; -.
DR   KO; K00311; -.
DR   OMA; PKTTFER; -.
DR   OrthoDB; EOG091G03C7; -.
DR   PhylomeDB; Q16134; -.
DR   TreeFam; TF105687; -.
DR   BioCyc; MetaCyc:HS10326-MONOMER; -.
DR   BRENDA; 1.5.5.1; 2681.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   ChiTaRS; ETFDH; human.
DR   GeneWiki; ETFDH; -.
DR   GenomeRNAi; 2110; -.
DR   PRO; PR:Q16134; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000171503; -.
DR   CleanEx; HS_ETFDH; -.
DR   ExpressionAtlas; Q16134; baseline and differential.
DR   Genevisible; Q16134; HS.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0017133; C:mitochondrial electron transfer flavoprotein complex; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; IDA:UniProtKB.
DR   GO; GO:0004174; F:electron-transferring-flavoprotein dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0043783; F:oxidoreductase activity, oxidizing metal ions with flavin as acceptor; ISS:UniProtKB.
DR   GO; GO:0048038; F:quinone binding; IDA:UniProtKB.
DR   GO; GO:0048039; F:ubiquinone binding; IDA:UniProtKB.
DR   GO; GO:0022900; P:electron transport chain; IDA:UniProtKB.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IMP:BHF-UCL.
DR   GO; GO:0022904; P:respiratory electron transport chain; IBA:GO_Central.
DR   GO; GO:0006979; P:response to oxidative stress; ISS:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR017896; 4Fe4S_Fe-S-bd.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR000103; Pyridine_nuc-diS_OxRdtase_2.
DR   PRINTS; PR00469; PNDRDTASEII.
DR   SUPFAM; SSF51905; SSF51905; 2.
DR   PROSITE; PS51379; 4FE4S_FER_2; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Electron transport; FAD; Flavoprotein;
KW   Glutaricaciduria; Iron; Iron-sulfur; Membrane; Metal-binding;
KW   Mitochondrion; Mitochondrion inner membrane; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transit peptide;
KW   Transport; Ubiquinone.
FT   TRANSIT       1     33       Mitochondrion. {ECO:0000255}.
FT   CHAIN        34    617       Electron transfer flavoprotein-ubiquinone
FT                                oxidoreductase, mitochondrial.
FT                                /FTId=PRO_0000008661.
FT   INTRAMEM    109    130       {ECO:0000250}.
FT   INTRAMEM    428    447       {ECO:0000250}.
FT   DOMAIN      577    606       4Fe-4S ferredoxin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00711}.
FT   NP_BIND      71     85       FAD. {ECO:0000255}.
FT   METAL       561    561       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   METAL       586    586       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   METAL       589    589       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   METAL       592    592       Iron-sulfur (4Fe-4S). {ECO:0000255}.
FT   BINDING     305    305       Ubiquinone; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   BINDING     306    306       Ubiquinone; via amide nitrogen.
FT                                {ECO:0000250}.
FT   MOD_RES      96     96       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q921G7}.
FT   MOD_RES     132    132       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q921G7}.
FT   MOD_RES     223    223       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q921G7}.
FT   MOD_RES     357    357       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q921G7}.
FT   MOD_RES     551    551       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      12     58       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055158.
FT   VARIANT      16     16       F -> C. {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075438.
FT   VARIANT      31     31       T -> I (in dbSNP:rs11559290).
FT                                {ECO:0000269|PubMed:12359134,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:8306995}.
FT                                /FTId=VAR_062966.
FT   VARIANT      49     49       Y -> C (in GA2C; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075439.
FT   VARIANT      82     82       S -> F (in GA2C).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075440.
FT   VARIANT      82     82       S -> P (in GA2C).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075441.
FT   VARIANT      84     84       A -> T (in GA2C; dbSNP:rs121964954).
FT                                {ECO:0000269|PubMed:19249206,
FT                                ECO:0000269|PubMed:20370797}.
FT                                /FTId=VAR_075442.
FT   VARIANT      94     94       H -> R (in dbSNP:rs1140065).
FT                                /FTId=VAR_055711.
FT   VARIANT     112    112       H -> Y (in GA2C).
FT                                {ECO:0000269|PubMed:16527485}.
FT                                /FTId=VAR_075443.
FT   VARIANT     127    127       L -> H (in GA2C; dbSNP:rs121964956).
FT                                {ECO:0000269|PubMed:19249206}.
FT                                /FTId=VAR_075444.
FT   VARIANT     138    138       L -> R (in GA2C; unknown pathological
FT                                significance; dbSNP:rs779896449).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075445.
FT   VARIANT     175    175       R -> H (in GA2C; dbSNP:rs121964955).
FT                                {ECO:0000269|PubMed:20370797}.
FT                                /FTId=VAR_075446.
FT   VARIANT     175    175       R -> L (in GA2C; dbSNP:rs121964955).
FT                                {ECO:0000269|PubMed:19249206}.
FT                                /FTId=VAR_075447.
FT   VARIANT     218    218       D -> N (in GA2C; unknown pathological
FT                                significance; dbSNP:rs748289922).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075448.
FT   VARIANT     222    222       Q -> P (in GA2C; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075449.
FT   VARIANT     262    262       L -> F (in GA2C; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075450.
FT   VARIANT     334    334       L -> P (in GA2C; unknown pathological
FT                                significance; dbSNP:rs377686388).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075451.
FT   VARIANT     346    346       H -> R (in GA2C; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075452.
FT   VARIANT     377    377       L -> P (in GA2C; unknown pathological
FT                                significance; dbSNP:rs387907170).
FT                                {ECO:0000269|PubMed:17412732}.
FT                                /FTId=VAR_075453.
FT   VARIANT     452    452       R -> K (in GA2C; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075454.
FT   VARIANT     456    456       P -> L (in GA2C; dbSNP:rs398124152).
FT                                {ECO:0000269|PubMed:12359134,
FT                                ECO:0000269|PubMed:17412732}.
FT                                /FTId=VAR_075455.
FT   VARIANT     456    456       P -> T (in GA2C).
FT                                {ECO:0000269|PubMed:16527485}.
FT                                /FTId=VAR_075456.
FT   VARIANT     483    483       P -> L (in GA2C; unknown pathological
FT                                significance; dbSNP:rs377656387).
FT                                {ECO:0000269|PubMed:17412732}.
FT                                /FTId=VAR_075457.
FT   VARIANT     562    562       P -> L (in GA2C).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075458.
FT   VARIANT     565    565       V -> L (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs769893690).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036134.
FT   VARIANT     590    590       K -> E (in GA2C).
FT                                {ECO:0000269|PubMed:17412732}.
FT                                /FTId=VAR_075459.
FT   VARIANT     611    611       G -> E (in GA2C; dbSNP:rs761669036).
FT                                {ECO:0000269|PubMed:12359134}.
FT                                /FTId=VAR_075460.
FT   CONFLICT    109    109       I -> V (in Ref. 3; CAD98030).
FT                                {ECO:0000305}.
FT   CONFLICT    456    456       P -> S (in Ref. 2; BAG65581).
FT                                {ECO:0000305}.
SQ   SEQUENCE   617 AA;  68495 MW;  099EBA36C59AF3D6 CRC64;
     MLVPLAKLSC LAYQCFHALK IKKNYLPLCA TRWSSTSTVP RITTHYTIYP RDKDKRWEGV
     NMERFAEEAD VVIVGAGPAG LSAAVRLKQL AVAHEKDIRV CLVEKAAQIG AHTLSGACLD
     PGAFKELFPD WKEKGAPLNT PVTEDRFGIL TEKYRIPVPI LPGLPMNNHG NYIVRLGHLV
     SWMGEQAEAL GVEVYPGYAA AEVLFHDDGS VKGIATNDVG IQKDGAPKAT FERGLELHAK
     VTIFAEGCHG HLAKQLYKKF DLRANCEPQT YGIGLKELWV IDEKNWKPGR VDHTVGWPLD
     RHTYGGSFLY HLNEGEPLVA LGLVVGLDYQ NPYLSPFREF QRWKHHPSIR PTLEGGKRIA
     YGARALNEGG FQSIPKLTFP GGLLIGCSPG FMNVPKIKGT HTAMKSGILA AESIFNQLTS
     ENLQSKTIGL HVTEYEDNLK NSWVWKELYS VRNIRPSCHG VLGVYGGMIY TGIFYWILRG
     MEPWTLKHKG SDFERLKPAK DCTPIEYPKP DGQISFDLLS SVALSGTNHE HDQPAHLTLR
     DDSIPVNRNL SIYDGPEQRF CPAGVYEFVP VEQGDGFRLQ INAQNCVHCK TCDIKDPSQN
     INWVVPEGGG GPAYNGM
//
